Results 171 to 180 of about 74,566 (254)

Upregulation of NGF/TrkA-Related Proteins in Dorsal Root Ganglion of Paclitaxel-Induced Peripheral Neuropathy Animal Model

Journal of Pain Research
Yeeun Kim,1,2,* Min-A Je,1,2,* Myeongguk Jeong,1,2 Hyeokjin Kwon,1,2 Aelee Jang,3 Jungho Kim,1,2 Go-Eun Choi1,2 1Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan, Busan, 46252, Republic of Korea;
Kim Y, Je MA, Jeong M, Kwon H, Jang A, Kim J, Choi GE   +6 more
doaj  

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors. [PDF]

Int J Clin Oncol, 2023
Naito Y, Mishima S, Akagi K, Hayashi N, Hirasawa A, Hishiki T, Igarashi A, Ikeda M, Kadowaki S, Kajiyama H, Kato M, Kenmotsu H, Kodera Y, Komine K, Koyama T, Maeda O, Miyachi M, Nishihara H, Nishiyama H, Ohga S, Okamoto W, Oki E, Ono S, Sanada M, Sekine I, Takano T, Tao K, Terashima K, Tsuchihara K, Yatabe Y, Yoshino T, Baba E.   +31 more
europepmc   +1 more source

Primary structure of the beta subunit of the DHP-sensitive calcium channel from skeletal muscle [PDF]

, 1989
Biel, Martin, Bosser, E., Flockerzi, Veit, Hofmann, Franz, Meyer, H. E., Regulla, S., Rohrkasten, A., Ruth, Peter   +7 more
core   +1 more source

Role of A-delta low threshold mechanoreceptors and tropomyosin receptor kinase B plasticity in at-level aversive pain after spinal cord injury. [PDF]

Exp Neurol
Parvin S, Jang K, Garraway SM.
europepmc   +1 more source

Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies

Investigational new drugs, 2012
G. Weiss, M. Hidalgo, M. Borad, D. Laheru, R. Tibes, R. Ramanathan, Lisa Blaydorn, G. Jameson, A. Jimeno, J. D. Isaacs, Angela Scaburri, M. A. Pacciarini, F. Fiorentini, M. Ciomei, D. Hoff   +14 more
semanticscholar   +1 more source

Preclinical Evaluation of the Oral Toxicity, Genotoxicity, and Safety Pharmacology of LPM4870108, a Novel Potent Tropomyosin Receptor Kinase Inhibitor. [PDF]

Pharmacol Res Perspect
Zhang X, Yuan B, Li C, Wang H, Wei S, Tian J, Duan S.   +6 more
europepmc   +1 more source

Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation. [PDF]

JCO Precis Oncol, 2022
Treis D, Umapathy G, Fransson S, Guan J, Mendoza-García P, Siaw JT, Wessman S, Gordon Murkes L, Stenman JJE, Djos A, Elfman LHM, Johnsen JI, Hallberg B, Palmer RH, Martinsson T, Kogner P.   +15 more
europepmc   +1 more source

Multi-Cancer Genome Profiling for Neurotrophic Tropomyosin Receptor Kinase (NTRK) Fusion Genes: Analysis of Profiling Database of 88,688 Tumors. [PDF]

Cancers (Basel)
Nishikubo H, Kawabata K, Kanei S, Aoyama R, Ma D, Sano T, Imanishi D, Sakuma T, Maruo K, Fan C, Yamamoto Y, Yashiro M.   +11 more
europepmc   +1 more source

Entrectinib-Induced Pericarditis with Cardiac Tamponade in a Patient with Neurotrophic Tropomyosin Receptor Kinase 1 Fusion-Positive Breast Cancer. [PDF]

Case Rep Oncol
Aoyama A, Yoshitomi Y, Shimomura A, Kawamura Y, Taniyama T, Kurozumi A, Kubota S, Hiroi Y, Shimizu C.   +8 more
europepmc   +1 more source

Dual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune Diseases. [PDF]

ACS Med Chem Lett, 2021
Abdel-Magid AF.
europepmc   +1 more source